The turmoil at the FDA continues with the news that Tracy Beth Høeg has been fired as acting head of the FDA's Center for ...

Tracy Beth Høeg said she was fired; Katherine Szarama departs as acting CBER director but remains at FDA, signaling rapid ...

FDA acting drug chief Dr. Tracy Beth Høeg claims she was fired, becoming the second high-ranking official to leave after ...

After FDA commissioner departure, acting CDER director Tracy Beth Høeg was fired May 15 amid agency leadership changes and policy disputes.

The U.S. Food and Drug Administration is shuffling its top drug and biologics regulators, days after the departure of former commissioner Marty Makary.

Editor's note: This article was updated on 11 January 2024 to correct a typo. The US Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) issued a report on the 55 novel ...

This story was originally published on PharmaVoice. To receive daily news and insights, subscribe to our free daily PharmaVoice newsletter. Dr. George Tidmarsh doesn’t have an established track record ...

The US Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) released a report on the 37 new drug therapies the Center approved in 2022, highlighting which had received ...

Patrizia Cavazzoni, director of FDA’s Center for Drug Evaluation and Research, has announced her retirement from the agency. Editor's Note: This story has been updated to include a comment by Glenn ...

After almost two years of anticipation, Janet Woodcock, director of the Center for Drug Evaluation and Research, has administration approval for organizational changes to bolster programs and policies ...